FOUNTAIN VALLEY, Calif.–(BUSINESS WIRE)–Kingston Technology Company, Inc., a world leader in memory products and technology…
Qualigen Therapeutics, Inc. Benedict M. Abugan CARLSBAD, Calif., Jan. 23, 2023 (GLOBE NEWSWIRE) — Qualigen…
SAN FRANCISCO, Jan. 23, 2023 (GLOBE NEWSWIRE) — AltruBio Inc. (“AltruBio” or “the Company”), a…
Approval granted by Mexico’s Food and Drug Administration, the Federal Commission for the Protection from…
Glen Rock, N.J., Jan. 23, 2023 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTC Markets: RSPI)…
23 January 2023 Clinigen divests Proleukin® to Iovance Biotherapeutics for £166.7 million The deal includes…
CORAL GABLES, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (NASDAQ: CPRX),…
Acquisition of Worldwide Rights to Proleukin® Provides Immediate and Ongoing Revenue and Secures IL-2 Supply…
WALTHAM, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) — Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical-stage…
Collaboration will support Sanofi’s use of CytoReason’s computational disease models to develop new targets for…
Matteo Levisetti, M.D., promoted to Chief Medical Officer, effective January 17, 2023 Acting CMO Kenneth…
Mr. Smith joins IO Biotech bringing over two decades of legal and compliance experience in…
– Patients reported clinically meaningful improvements across multiple health-related quality of life measures following 52…
BURNABY, British Columbia, Jan. 23, 2023 (GLOBE NEWSWIRE) — Qu Biologics Inc., a clinical stage…
WHITE PLAINS, N.Y., Jan. 23, 2023 (GLOBE NEWSWIRE) — Iantrek today announced the publication of…
LEXINGTON, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the…
Achieves Record 4x Improvement in Time-To-Result to Provide Test Results in Under 1 Minute NEW YORK,…
Overall response rate (ORR) of 23% and disease control rate (DCR) of 76% in expanded…
UTRECHT, The Netherlands and PHILADELPHIA, Jan. 23, 2023 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq:…
Bavituximab plus pembrolizumab combination achieved a 62.5% response rate in biomarker positive subgroup of hepatocellular…